India's humanoid robots library · Specs, prices, news and buying guides - no hype.
RobotWale
Applications Elder-Care Robots Hands-on coverage

Elder-Care Robots: Shipping Hardware, Pilots, and India Market Reality

📅 Published ⏰ 6 min read 👤 By RobotWale Editors
A person with a bionic hand holding a tablet, showcasing advanced prosthetic technology.
Summary A grounded assessment of shipping elder-care companions like ElliQ, Paro, and Lovot, graded by hardware availability, pilot deployments, and India import realities.

Elder-Care Robots: Shipping Hardware, Pilots, and India Market Reality

The elder-care robotics segment has moved past conceptual renderings and into limited commercial circulation. This article grades available assistive home companions by verifiable deployment status, manufacturer specifications, and realistic India market conditions. We prioritize shipping hardware first, pilot deployments second, and public announcements last, in line with RobotWale's evaluation framework.

Grading the Market: Hardware First, Pilots Second

Elder-care robotics claims must be separated into three tiers: (1) units manufactured, tested, and available for purchase; (2) active pilot deployments in care facilities or private homes with published outcomes; and (3) press releases or roadmaps that have not yet reached the supply chain. The current landscape contains three primary shipping hardware categories: proactive AI companions, therapeutic biofeedback robots, and mobile emotional-computing units. Each serves distinct clinical and domestic use cases, and none replace licensed medical or nursing staff.

Shipping Hardware: Current Commercial Units

The following units have crossed from prototype to commercial release. Specifications are drawn from manufacturer sheets, press releases, and independent teardowns or demo videos.

ElliQ (Intuition Robotics)

Grade: Shipping Hardware. Commercial release began in 2023, with sustained production reported through 2024. ElliQ is a desktop AI companion designed for older adults. The unit features a 10-inch display, directional microphone array, dual speakers, and a gesture-capable arm. Intuition Robotics markets ElliQ as a proactive assistant that initiates conversations, schedules medication reminders, facilitates video calls, and adapts to user preferences over time. The system runs on a cloud-assisted AI stack with on-device privacy filters. Battery capacity is not officially disclosed in public spec sheets, but the unit operates on a dedicated dock with continuous power management. Intuition Robotics has published case studies from senior living facilities in the United States and Israel, noting improved engagement metrics but explicitly stating that ElliQ does not perform clinical assessments or physical assistance. Pricing sits at approximately $3,000–$4,000 USD depending on subscription tiers for advanced AI features. No official Indian distributor exists as of 2024; landed cost estimates for direct import range from ₹3.5 lakh to ₹4.5 lakh, subject to 40–50% import duties and GST.

Paro (AIST / Seiko Epson)

Grade: Shipping Hardware. Paro has been in continuous production since the late 1990s, with commercial distribution managed by Seiko Epson and licensed regional partners. The unit is a therapeutic seal robot designed for dementia care and emotional regulation. It does not run general-purpose AI; instead, it uses a biofeedback sensor suite (touch, light, sound, posture) mapped to behavioral algorithms that simulate responsiveness. Paro's hardware includes a lightweight ABS body, internal microphones, cameras, and tactile sensors. Clinical validation comes from peer-reviewed studies and facility deployments across Japan, Europe, and North America. The robot does not provide navigation, medication management, or fall detection. Manufacturer pricing ranges from $6,000 to $8,000 USD. In India, Paro is available only through specialized medical distributors and research institutions, with landed costs estimated at ₹6–8 lakh. It is classified as a therapeutic device rather than a consumer robot.

Lovot (Groovy)

Grade: Shipping Hardware. Developed by Groovy (Japan), Lovot entered commercial circulation in 2018 and has maintained steady production. The unit features a mobile base, expressive LCD face, infrared proximity sensors, and a 360-degree camera system. Lovot emphasizes emotional bonding through follow-along behavior, voice interaction, and physical gestures. Groovy's technical documentation highlights a modular architecture with replaceable batteries and over-the-air updates. The robot is not marketed as a medical or assistive device but as a companion unit for households. Pricing in Japan is approximately ¥400,000–¥500,000 (roughly $2,700–$3,400 USD). Indian availability is limited to private importers and tech enthusiasts, with landed costs estimated at ₹4–5 lakh. Independent reports note that Lovot's mobility range is short (approximately 100 meters per charge) and its interaction model is pre-programmed rather than fully autonomous.

Pilot Deployments and Real-World Validation

Pilot deployments provide the most reliable signal of elder-care robot utility. The following categories have published outcomes or facility reports:

Announcements of broader elder-care robotics initiatives frequently outpace supply chain readiness. Claims of autonomous medication dispensing, fall detection, or clinical diagnosis remain in pilot or regulatory review stages and should not be treated as commercial features.

India Availability and Landed Cost Estimates

India's elder-care robotics market remains import-dependent. No domestic manufacturer currently ships a certified elder-care companion robot at scale. The following factors shape availability and pricing:

Technical, Safety, and Regulatory Notes

Elder-care robots must meet specific engineering and compliance standards before deployment in residential or care settings:

Conclusion

Elder-care robotics has reached a tangible hardware phase, but utility remains narrowly scoped. ElliQ, Paro, and Lovot are shipping units with documented specifications and pilot data, yet none provide physical assistance, clinical diagnosis, or autonomous care management. India's market is constrained by import duties, limited distribution, and regulatory classification differences. Prospective buyers and facilities should evaluate robots by verified hardware status, published pilot outcomes, and total cost of ownership rather than marketing claims. The sector will mature only when domestic manufacturing, certified clinical validation, and standardized service networks align.

References

✓ Key takeaways

Editorial note Robot specs, release timelines and India prices shift quickly. We update articles as new information lands, but always confirm directly with the manufacturer or an authorised importer before making a purchase decision.

Get the weekly RobotWale brief

One short email a week. New humanoid launches, prices that actually matter in India, hands-on reviews and the research papers worth reading. No hype. No sponsored fluff.

Free. Unsubscribe any time. We will never share your email.

Browse the library